WEBINAR | Oncology Drug Development in 2026: From Scientific Innovation to Global Execution

Oncology innovation is accelerating—but how do sponsors determine which advances are ready to move into clinical development and scale globally?

In this webinar, Syneos Health oncology experts Catarina Ribeiro, MD, and Joao Dias, MD, join Alberto Puccini, MD, of Humanitas Cancer Center; Martin Forster, MD, of University College London and University College Hospital; and Paul Nathan, MBBS, PhD, FRCP, of Mount Vernon Cancer Centre. Informed by a Syneos Health oncology community survey, they discuss:

• How emerging evidence, biomarkers, dose optimization, and adaptive approaches can inform earlier development decisions
• Where AI and multimodal data can meaningfully support tumor selection, patient identification, and trial strategy
• What it takes to align trial design, regulatory requirements, and execution across geographies

Watch the webinar recordings to explore the decisions that connect scientific promise with global clinical development.

Broadcast 1

Broadcast 2